IgA Glycosylation and Immune Complex Formation in IgAN

Overview

Journal Semin Immunopathol

Publisher Springer

Specialties Allergy & Immunology
Pathology

Date 2021 Sep 27

PMID 34570260

Citations 32

Authors

Hitoshi Suzuki

Jan Novak

Affiliations

Soon will be listed here.

Abstract

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. This disease, discovered in 1968, is characterized by IgA-IgG glomerular immunodeposits with a mesangial pattern. It is thought that these immunodeposits originate from the immune complexes formed in the circulation. It is hypothesized that the pathogenesis of IgAN is driven by aberrant glycoforms of IgA1 (galactose-deficient IgA1, Gd-IgA1). Gd-IgA1, in genetically susceptible individuals, represents the initiating factor for the formation of circulating immune complexes due to its recognition by IgG autoantibodies and the subsequent formation of pathogenic IgA1-IgG immune complexes. Complement activation through alternative and/or lectin pathways is likely playing an important role in the pathogenic properties of these complexes and may further upregulate local inflammatory responses and glomerular injury.

Citing Articles

IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expression.

Falck D, Sokolova M, Koeleman C, Irumva V, Kirchner P, Schulz S Cell Commun Signal. 2025; 23(1):92.

PMID: 39962487 PMC: 11834270. DOI: 10.1186/s12964-025-02088-0.

Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis.

Umezawa Y, Aoki R, Ichikawa D, Suzuki Y, Suzuki T J Nephrol. 2025; .

PMID: 39946052 DOI: 10.1007/s40620-025-02213-9.

Efficacy and safety of telitacicept in IgA nephropathy: a real-world study.

Dong L, Yang D, Qin A, Wang S, Tang Y, Tan J Ren Fail. 2025; 47(1):2449580.

PMID: 39780498 PMC: 11721934. DOI: 10.1080/0886022X.2025.2449580.

FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD.

Shang Y, Wang Z, Yang F, Wang W, Tang Q, Guo X Mol Med. 2024; 30(1):222.

PMID: 39563263 PMC: 11577590. DOI: 10.1186/s10020-024-00994-6.

Thymic stromal lymphopoietin signaling in B cells from progenitors to plasma cells.

Domeier P, Ziegler S J Leukoc Biol. 2024; 117(2).

PMID: 39373526 PMC: 11878999. DOI: 10.1093/jleuko/qiae216.

References

Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomi M, Roccatello D . IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol. 1984; 57(3):583-90. PMC: 1536277. View

Floege J, Feehally J . The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol. 2015; 12(3):147-56. DOI: 10.1038/nrneph.2015.208. View

Conley M, Cooper M, Michael A . Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980; 66(6):1432-6. PMC: 371631. DOI: 10.1172/JCI109998. View

Novak J, Vu H, Novak L, Julian B, Mestecky J, Tomana M . Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int. 2002; 62(2):465-75. DOI: 10.1046/j.1523-1755.2002.00477.x. View

Macpherson A, Yilmaz B, Limenitakis J, Ganal-Vonarburg S . IgA Function in Relation to the Intestinal Microbiota. Annu Rev Immunol. 2018; 36:359-381. DOI: 10.1146/annurev-immunol-042617-053238. View

Kunkel E, Butcher E . Plasma-cell homing. Nat Rev Immunol. 2003; 3(10):822-9. DOI: 10.1038/nri1203. View

Buren M, Yamashita M, Suzuki Y, Tomino Y, Emancipator S . Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. Contrib Nephrol. 2007; 157:50-5. DOI: 10.1159/000102304. View

Litinskiy M, Nardelli B, Hilbert D, He B, Schaffer A, Casali P . DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002; 3(9):822-9. PMC: 4621779. DOI: 10.1038/ni829. View

Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K . Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy. JAMA Netw Open. 2019; 2(5):e194772. PMC: 6547111. DOI: 10.1001/jamanetworkopen.2019.4772. View

10.

Bellur S, Troyanov S, Cook H, Roberts I . Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 2011; 26(8):2533-6. DOI: 10.1093/ndt/gfq812. View

11.

Saha M, Julian B, Novak J, Rizk D . Secondary IgA nephropathy. Kidney Int. 2018; 94(4):674-681. PMC: 6981247. DOI: 10.1016/j.kint.2018.02.030. View

12.

Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R . IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant. 2006; 21(9):2478-84. DOI: 10.1093/ndt/gfl240. View

13.

Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K . Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008; 3(5):1301-7. PMC: 2518790. DOI: 10.2215/CJN.00310108. View

14.

Yel L . Selective IgA deficiency. J Clin Immunol. 2010; 30(1):10-6. PMC: 2821513. DOI: 10.1007/s10875-009-9357-x. View

15.

Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr A, Renfrow M . The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011; 22(10):1795-803. PMC: 3892742. DOI: 10.1681/ASN.2011050464. View

16.

Fellstrom B, Barratt J, Cook H, Coppo R, Feehally J, De Fijter J . Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 2017; 389(10084):2117-2127. DOI: 10.1016/S0140-6736(17)30550-0. View

17.

Bene M, Faure G, Hurault de Ligny B, Kessler M, Duheille J . Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest. 1983; 71(5):1342-7. PMC: 436997. DOI: 10.1172/jci110886. View

18.

Chen A, Yang S, Lin T, Ka S . IgA nephropathy: clearance kinetics of IgA-containing immune complexes. Semin Immunopathol. 2018; 40(6):539-543. DOI: 10.1007/s00281-018-0708-7. View

19.

Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L . IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005; 67(2):504-13. DOI: 10.1111/j.1523-1755.2005.67107.x. View

20.

Mestecky J, Raska M, Julian B, Gharavi A, Renfrow M, Moldoveanu Z . IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol. 2012; 8:217-40. DOI: 10.1146/annurev-pathol-011110-130216. View